Veracyte officer plans $163K stock resale

An officer of Veracyte, Inc. has filed a Rule 144 notice to resell up to 3,652 shares of common stock through a broker.

Rhea-AI Filing Summary

VERACYTE, INC. (VCYT) is the issuer of common stock for which officer Rebecca Chambers has filed a notice of proposed resale under Rule 144. The notice covers up to 3,652 shares of common stock, associated with restricted stock units held for her account.

The planned sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated aggregate market value of approximately $163,134.84 and a proposed sale date of September 4, 2026 on Nasdaq.

Key Figures

Shares covered by Rule 144 notice: 3,652 shares Aggregate market value of shares: $163,134.84 Proposed sale date: September 4, 2026 +2 more

5 metrics

Shares covered by Rule 144 notice 3,652 shares Maximum Veracyte common shares referenced for potential resale by officer Rebecca Chambers

Aggregate market value of shares $163,134.84 Value listed for the 3,652 Veracyte common shares in the securities information section

Proposed sale date September 4, 2026 Date listed in the securities information section for the proposed Nasdaq sale

Security type Common stock Class of Veracyte securities referenced in the Rule 144 notice

Underlying award type Restricted Stock Units Form 144 identifies the securities to be sold as tied to restricted stock units

Key Terms

Rule 144, Restricted Stock Units, aggregate market value, Nasdaq

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 09/02/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

aggregate market value financial

"Common ... 3652 | 163134.84 | ..."

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Nasdaq market

"80390731 | 09/04/2026 | NASDAQ"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for Veracyte, Inc. (VCYT)?

The Form 144 reports that an officer, Rebecca Chambers, has given notice of a planned resale under Rule 144 of up to 3,652 shares of Veracyte common stock. This is a disclosure of a potential sale, not an indication of company-level financial results.

How many Veracyte (VCYT) shares are covered by this Form 144?

The notice covers up to 3,652 shares of Veracyte common stock, associated with restricted stock units. This is the maximum amount referenced for potential resale under this specific Rule 144 filing.

What is the approximate market value of the Veracyte (VCYT) shares in this Form 144?

The filing lists an aggregate market value of $163,134.84 for the 3,652 shares of Veracyte common stock referenced in the notice, based on the information provided in the securities section.

Who is selling Veracyte (VCYT) shares under this Rule 144 notice?

The person for whose account the securities are to be sold is Rebecca Chambers, identified as an officer of Veracyte, Inc. The filing specifies that the securities relate to restricted stock units issued by the company.

Which broker is handling the planned Veracyte (VCYT) share sale?

The planned resale is to be handled through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, with the shares proposed to be sold on Nasdaq as stated in the securities information section.

When are the Veracyte (VCYT) shares proposed to be sold under this Form 144?

The securities information section lists a proposed sale date of September 4, 2026, and the securities-to-be-sold section references September 2, 2026 in connection with the restricted stock units, providing the timing context for the planned resale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 04:34 PM EDT Accepted by SEC EDGAR 09/04/2026 - 04:33 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001823563
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERACYTE INC COM
SEC File Number	001-36156
Address of Issuer	6000 Shoreline Court, Suite 300 South San Francisco CALIFORNIA 94080
Phone	6502436300
Name of Person for Whose Account the Securities are To Be Sold	REBECCA CHAMBERS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3652	163134.84	80390731	09/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/02/2026	Restricted Stock Units	Issuer			3652	09/02/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/21/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Rebecca Chambers
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)